POSITION SUMMARY:

The Head, Market Access Portfolio Strategy is a strategic connector responsible for integrating payer strategies, scaling long-term Value & Access (V&A) capabilities, embedding AI-powered solutions, and leading early-stage access planning across a complex and diverse portfolio. This role directly supports the market access strategy for high-impact customer groups—including the Big 3 (Zinc/CVS, Ascent/ESI, Emisar/United/OptumRx)—by supporting the three dedicated Account Heads with coordinated content, pricing frameworks, and pull-through strategies that span therapeutic areas.
The role also maintains a broad enterprise view of market access profitability, including GTN dynamics, access investment trade-offs, and payer segmentation strategy—ensuring the organization maximizes value realization while enhancing executional efficiency across brands and development stages.

REQUIRED QUALIFICATIONS:

• 10+ years of progressive experience in market access, payer strategy, pricing, or related functions within pharmaceutical or biotech industries.
• Deep expertise in GTN drivers, payer landscape, and specialty product market access across diverse therapeutic areas.
• Proven experience managing cross-functional teams and driving enterprise-level strategic projects.
• Demonstrated success implementing digital or AI-enabled capabilities in commercial environments.
• Ability to operate effectively at both strategic and tactical levels within matrixed organizations.

PREFERRED QUALIFICATIONS:

• Experience integrating AI or advanced analytics platforms into payer strategy or pricing operations.
• Exceptional change management skills to lead capability evolution in dynamic market environments.
• Track record of driving cross-business synergies and translating strategic insights into actionable plans.

• Serve as the enterprise connector across Value & Access, unifying execution across therapeutic areas and enabling coordinated customer, pricing, and pull-through strategies.
• Lead a senior team across HEVA, customer marketing, future V&A enablement, and portfolio execution to drive enterprise value.
• Support BD assets from US perspective, shaping Target Product Profiles, GTN assumptions, and payer value hypotheses.
• Guide payer evidence planning and ensure seamless handoff to brand V&A teams in coordination with global access functions.
• Build scalable, AI-enabled tools and workflows to accelerate delivery of payer materials, reduce vendor costs, and modernize V&A content operations.
• Lead alignment of payer strategy for the Big 3 (Zinc/CVS, Ascent/ESI, Emisar/United/OptumRx), partnering with Account Heads to drive impact through integrated pricing, contracting, and customer engagement models.
• Responsible for GOA 1 contract approvals across specialty portfolio
• Lead 20% of market access brand budget for dynamic resource allocation across market access
• Partner with HEVA and insights to embed GTN trends and macroeconomic factors into access strategy.
• Oversee operational execution, resource prioritization, and KPI tracking across market access initiatives.
• Develop future V&A talent through capability planning, mentorship, and training to build a high-performing, future-ready team.